The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 28, 2020

Filed:

Apr. 29, 2016
Applicant:

Industrial Technology Research Institute, Hsinchu, TW;

Inventors:

Chih-Peng Liu, Hsinchu, TW;

Ya-Chin Lo, Taichung, TW;

Ming-Cheng Wei, Taoyuan, TW;

Maggie Lu, Zhudong Township, Hsinchu County, TW;

Shuen-Hsiang Chou, Zhunan Township, Miaoli County, TW;

Shih-Ta Chen, New Taipei, TW;

Hsiang-Wen Tseng, New Taipei, TW;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 33/24 (2019.01); A61K 9/51 (2006.01); A61K 9/00 (2006.01); A61K 31/555 (2006.01);
U.S. Cl.
CPC ...
A61K 9/5161 (2013.01); A61K 9/0019 (2013.01); A61K 31/555 (2013.01); A61K 33/24 (2013.01);
Abstract

Disclosed is an intralymphatic delivery method for treating lymphatic cancer using hyaluronan nanoparticles. These nanoparticles include a hyaluronic acid derivative and a platinum compound. The hyaluronan derivative includes hyaluronic acid, modified histidine and optionally one or more of a polymer or a C-Calkyl. The hyaluronic acid derivative may include linking group(s) that connect the polymer or the C-Calkyl to the hyaluronic acid. The platinum compound includes dichloro(1,2-diaminocyclohexane) platinum (DACHPt), cisplatin and oxaliplatin. This intralymphatic delivery method offers significant advantages for the use of platinum medicines in treating lymphatic cancer.


Find Patent Forward Citations

Loading…